What is CARDIOX?
CARDIOX is at the forefront of AI-powered biosensing, developing a platform that unifies multiple sensing modalities to deliver real-time cardiovascular, metabolic, and behavioral health insights. This innovative technology is tailored for a diverse clientele, including sports organizations, fitness centers, healthcare providers, research institutions, and corporate wellness programs. By offering advanced metrics such as cuffless blood pressure, hydration status, and stress monitoring, CARDIOX empowers organizations to elevate performance, enhance patient engagement, and advance research outcomes. The platform's adaptability supports both individual and group monitoring, making it a versatile solution for a wide spectrum of health and fitness applications.
How much funding has CARDIOX raised?
CARDIOX has raised a total of $12.6M across 4 funding rounds:
Private Equity
$786K
Debt
$652K
Private Equity
$8M
Unspecified
$3.2M
Private Equity (2009): $786K, investors not publicly disclosed
Debt (2010): $652K, investors not publicly disclosed
Private Equity (2011): $8M, investors not publicly disclosed
Unspecified (2014): $3.2M featuring Early Stage Partners and Reservoir Venture Partners
Key Investors in CARDIOX
Early Stage Partners
Early Stage Partners is a venture capital firm established in 2001, focused on supporting technology companies in the Midwest. The firm provides capital, advice, and connections to promising early-stage companies, aiming to foster success for entrepreneurs and investors alike.
Reservoir Venture Partners
Reservoir Venture Partners operates within the Venture Capital & Private Equity industry, focusing on providing investment and strategic support to growing companies.
What's next for CARDIOX?
The recent major strategic investment signals a pivotal growth phase for CARDIOX. This capital infusion is expected to accelerate the company's expansion, likely focusing on scaling its AI-driven biosensing platform and broadening its market reach. Strategic partnerships and further technological development are anticipated as CARDIOX aims to solidify its position in the competitive health-tech landscape. The company's trajectory suggests a strong emphasis on leveraging its unique data insights to drive innovation in preventative health and performance optimization.
See full CARDIOX company page
